Oct 4- A new drug to treat a breathing disorder that is the leading cause of death of premature babies cleared a regulatory hurdle, allowing Discovery Laboratories Inc to release it in the United States before the end of the year.
Here's how to profit from the coming Alexza FDA run down.
NEW YORK-- Shares of Discovery Laboratories Inc. sank Wednesday after the drug developer said the availability of a new treatment for respiratory distress syndrome may be delayed until next year's second quarter. Discovery said it has started a plan to improve the method, and it will submit the updated specifications to the Food and Drug Administration.
Yet another Vivus takeover rumor circulating through the market Tuesday got me thinking: When do most biotech and drug takeovers happen?
After a hot streak, biotech stocks lose value as clinical trials fail.
Shares of Pandora plunged Wednesday, as the online-streaming music operator forecast a weak outlook for 2012.
Daytime superstar Oprah Winfrey will be moving to nighttime to host a show on her new cable channel.
Stocks logged their best quarter in 11 years, helped by the weak dollar, despite today's soft landing.
Stocks retreated Tuesday as weak readings on manufacturing and jobs offset a a report that showed the economy wasn't in as bad a shape as first expected over the summer.
Futures indicated a positive open for Wall Street on Tuesday, the last day of the third quarter, as European stocks rose and were set to lock in their best quarterly performance in nearly a decade.